NR565 ADVANCED PHARMACOLOGY
CARE OF THE FUNDAMENTALS EXAM
QUESTIONS AND VERIFIED ANSWERS
(2026/ 2027 UPDATE)- CHAMBERLAIN
1. A patient is prescribed a medication that is a known substrate of the CYP3A4 enzyme. If the
patient begins drinking grapefruit juice daily, what is the primary pharmacokinetic concern?
A. Decreased drug absorption due to gastric pH changes
B. Reduced drug efficacy due to enzyme induction
C. Increased serum drug levels due to inhibition of metabolism
D. Enhanced renal excretion of the drug
Answer: C
Conceptual Explanation: Grapefruit juice is a potent inhibitor of the CYP3A4 enzyme
system. When the enzyme is inhibited, the metabolism of substrate drugs decreases,
leading to elevated serum levels and potential toxicity.
2. When assessing the Volume of Distribution (Vd) of a drug, a very high Vd typically indicates
which of the following?
A. The drug is primarily confined to the intravascular space
B. The drug is highly protein-bound in the plasma
,C. The drug is widely distributed into body tissues and fat
D. The drug is rapidly cleared by the kidneys
Answer: C
Conceptual Explanation: A high Volume of Distribution (Vd) suggests that the drug has
moved out of the plasma and into the tissues, often seen with highly lipophilic drugs.
3. Which physiological change in the geriatric population most significantly affects the renal
clearance of drugs?
A. Increased glomerular filtration rate (GFR)
B. Decreased renal blood flow and nephron count
C. Increased tubular secretion capacity
D. Decreased urine pH
Answer: B
Conceptual Explanation: Aging is associated with a physiological decline in renal blood
flow and a decrease in the number of functional nephrons, leading to reduced GFR and
impaired drug clearance.
4. According to the WHO Guide to Good Prescribing, what is the first step in the rational
prescribing process?
A. Define the patient’s problem
B. Choose a P-drug (Personal drug)
, C. Specify the therapeutic objective
D. Verify the suitability of the drug
Answer: A
Conceptual Explanation: The first step in the rational prescribing process is defining the
patient’s problem, which involves making a diagnosis and identifying the need for
intervention.
5. A drug that binds to a receptor and produces a sub-maximal response compared to a full
agonist, while also potentially blocking a full agonist, is known as a:
A. Partial agonist
B. Inverse agonist
C. Competitive antagonist
D. Non-competitive antagonist
Answer: A
Conceptual Explanation: A partial agonist has intrinsic activity less than a full agonist but
can occupy receptor sites, thereby acting as an antagonist in the presence of a full agonist.
6. Under the Controlled Substances Act, which schedule of drugs has a high potential for
abuse, no currently accepted medical use in the US, and a lack of accepted safety?
A. Schedule III
B. Schedule II
CARE OF THE FUNDAMENTALS EXAM
QUESTIONS AND VERIFIED ANSWERS
(2026/ 2027 UPDATE)- CHAMBERLAIN
1. A patient is prescribed a medication that is a known substrate of the CYP3A4 enzyme. If the
patient begins drinking grapefruit juice daily, what is the primary pharmacokinetic concern?
A. Decreased drug absorption due to gastric pH changes
B. Reduced drug efficacy due to enzyme induction
C. Increased serum drug levels due to inhibition of metabolism
D. Enhanced renal excretion of the drug
Answer: C
Conceptual Explanation: Grapefruit juice is a potent inhibitor of the CYP3A4 enzyme
system. When the enzyme is inhibited, the metabolism of substrate drugs decreases,
leading to elevated serum levels and potential toxicity.
2. When assessing the Volume of Distribution (Vd) of a drug, a very high Vd typically indicates
which of the following?
A. The drug is primarily confined to the intravascular space
B. The drug is highly protein-bound in the plasma
,C. The drug is widely distributed into body tissues and fat
D. The drug is rapidly cleared by the kidneys
Answer: C
Conceptual Explanation: A high Volume of Distribution (Vd) suggests that the drug has
moved out of the plasma and into the tissues, often seen with highly lipophilic drugs.
3. Which physiological change in the geriatric population most significantly affects the renal
clearance of drugs?
A. Increased glomerular filtration rate (GFR)
B. Decreased renal blood flow and nephron count
C. Increased tubular secretion capacity
D. Decreased urine pH
Answer: B
Conceptual Explanation: Aging is associated with a physiological decline in renal blood
flow and a decrease in the number of functional nephrons, leading to reduced GFR and
impaired drug clearance.
4. According to the WHO Guide to Good Prescribing, what is the first step in the rational
prescribing process?
A. Define the patient’s problem
B. Choose a P-drug (Personal drug)
, C. Specify the therapeutic objective
D. Verify the suitability of the drug
Answer: A
Conceptual Explanation: The first step in the rational prescribing process is defining the
patient’s problem, which involves making a diagnosis and identifying the need for
intervention.
5. A drug that binds to a receptor and produces a sub-maximal response compared to a full
agonist, while also potentially blocking a full agonist, is known as a:
A. Partial agonist
B. Inverse agonist
C. Competitive antagonist
D. Non-competitive antagonist
Answer: A
Conceptual Explanation: A partial agonist has intrinsic activity less than a full agonist but
can occupy receptor sites, thereby acting as an antagonist in the presence of a full agonist.
6. Under the Controlled Substances Act, which schedule of drugs has a high potential for
abuse, no currently accepted medical use in the US, and a lack of accepted safety?
A. Schedule III
B. Schedule II
